Initial comparative study on the efficacy of single agent gemcitabine versus combination gemcitabine and cisplatin in Filipino patients with advanced non-small cell lung cancer
Explore this paper's citation graph
- Type
- article
- Published
- 2000-09-01
- Cited by
- 3
- References
- 0
- OpenAlex
- https://openalex.org/W2072728781
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:72691417
Keywords
Gemcitabine, Medicine, Cisplatin, Oncology, Lung cancer
References
No references recorded for this paper.
Cited by
- WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease.
- Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis.
- Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.
Related papers
- A Comparison of Gemcitabine in Two Doses for Stage III or IV Non-small Cell Lung Cancer: a Multi-Institutional Phase II Study
- Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis.
- A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer
- Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study
- S-1＋Gemcitabine 併用化学療法が著効し長期生存中の進行膵癌術後肝転移の1 例
- Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer.
- Efficiency and Tolerance of Aranose Combinations with Cisplatin and Gemcitabine in Experimental Lung Cancer